Abhinav Bhalaik shares his views with NDTV Profit
We are pleased to share that our Partner, Abhinav Bhalaik, recently joined NDTV Profit’s The Big Question, in conversation with Vikram Oza, to discuss the Supreme Court’s observations on pharmaceutical marketing practices and the need for a legally enforceable regulatory framework governing inducements offered by pharmaceutical companies to medical professionals.
Abhinav highlighted that the existing Uniform Code for Pharmaceutical Marketing Practices (UCPMP), 2024, is largely directive in nature and does not prescribe sufficiently enforceable consequences for non-compliance. He emphasized the need for a statutory framework that establishes clear accountability and penalties for violations, while noting that the existing code could serve as a useful foundation for such legislation.
He also discussed the importance of transparency and disclosure in regulating interactions between pharmaceutical companies and healthcare professionals, emphasizing that disclosure requirements must be systematic, meaningful and supported by enforceable consequences to ensure effective compliance.
.png)
Argus Partners Advises Popo Global and its Founders on ₹532…
.png)
.png)
.png)
7A, 7th Floor, Tower C, Max House,
Okhla Industrial Area, Phase 3
New Delhi – 110020
The rules of the Bar Council of India do not permit advocates to solicit work or advertise in any manner. This website has been created only for informational purposes and is not intended to constitute solicitation, invitation, advertisement or inducement of any sort whatsoever from us or any of our members to solicit any work in any manner. By clicking on 'Agree' below, you acknowledge and confirm the following:
a) there has been no solicitation, invitation, advertisement or inducement of any sort whatsoever from us or any of our members to solicit any work through this website;
b) you are desirous of obtaining further information about us on your own accord and for your use;
c) no information or material provided on this website is to be construed as a legal opinion and use of this website will not create any lawyer-client relationship;
d) while reasonable care has been taken in ensuring the accuracy of the contents of the website, Argus Partners shall not be responsible for the results of any actions taken on the basis of information provided in this website or for any error or omission in the website; and
e) in cases where the user has any legal issues, the user must seek independent legal advice.
.png)
.png)
.png)